TSS
DBTX

Two Sigma Securities’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Two Sigma Securities’s Portfolio DBTX Stock Details DBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-17,683
Closed -$74K – 3258
2022
Q2 		$74K Buy
+17,683
New +$41.8K ﹤0.01% 1797

Other funds holding DBTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $4.26B AUM 5.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Two Sigma Securities's DBTX Position: Q3 2022 in Review

Two Sigma Securities sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2022, closing a stake of 17,683 shares — an estimated $74K sold.

Two Sigma Securities first reported a position in DBTX in Q2 2022 and held it in 1 quarter. The position peaked at $74K in Q2 2022. 40 funds tracked by Wall St. Rank hold DBTX as of Q3 2022.

  • Two Sigma Securities reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Securities sold 17,683 Decibel Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $74K.
  • Two Sigma Securities first reported a position in Decibel Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Two Sigma Securities's Decibel Therapeutics, Inc. Common Stock position peaked at $74K in Q2 2022.
  • 40 funds tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Two Sigma Securities's 13F filing for Q3 2022, filed 14 Nov 2022.